Categories
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
Recommended Sites
- Bed Bug Registry
- Bing Search
- Body Mass Index Calculator
- Broken Link Checker
- Browser Shots
- Caring Medical
- Cheap Pharmacy Online
- Conscious Evolution
- Cryomedical Blog
- Free Health Insurance Quote
- Free Loan Quote
- Genistein Net
- Google Search
- HGH
- HGH Prescription
- HGH Side Effects
- HGH Therapy
- Hormone Decline Graphs / Calculator
- Injectable Testosterone
- International American University
- Medical Dictionary Search
- Medical Drugs Search
- Medical School Review
- Medical Symptoms Search
- New York City Real Estate
- Palm Beach Real Estate
- POLIMEDICAL CENTRO POLISPECIALISTICO
- Quality of Life Assessment
- Ron Paul 2012
- Ron Paul TV
- SEO Web Design
- Start Your Own Internet Services Company
- Stem Cell Therapy for Brain Injury
- Stem Cell Therapy for Cerebral Palsy
- Stem Cell Therapy for Diabetes
- Stem Cell Therapy for Spinal Cord Injury
- Stem Cell Therapy for Stroke
- Stem Cells China
- Website Speed Analysis
- WholeSale Domain Names
- Windsor Medical School
- Yahoo Search
Author Archives: lytbtj
Regenerative medicine company begins enrollment in critical limb ischemia trial
Regenerative medicine startup Juventas Therapeutics has begun enrollment in a phase 2a trial of critical limb ischemia patients. The Cleveland-based company, which recently secured an important investment from Takeda Pharmaceuticals, is planning to enroll 48 patients and complete enrollment early next year, CEO Rahul Aras said. Juventas technology, called JVS-100, works by recruiting stem cells from the bone marrow to create new blood vessels Continue reading
Posted in Regenerative Medicine
Tagged a-heart-attack, advertisement, decreases-blood, easy-procedure, juventas, regenerative, stromal-cell-, well-as-three, which-includes
Comments Off
Amy McGuire, JD, PhD, "Genomic Medicine: Ethical, Legal
15-05-2012 13:33 ISH Spring Lecture Series 5/10/2012 “Genomic Medicine: Ethical, Legal & Social Implications” Technological advances have made it possible for individuals to receive vast amounts of information about their genetic susceptibility to disease. How best to integrate genomics into routine clinical care is a critical policy issue. How much and what type of information should be communicated to patients, included in their health record, and followed up on for diagnostic, preventative, and treatment purposes Continue reading
Posted in Genetic medicine
Tagged associate, baylor-college, center, ethical, health, implications, legal, medical, medical-ethics, medicine, research-, social, spring, spring-lecture, technological
Comments Off
Abraham’s genetic threads | Gene Expression
Every few days my Google Alerts have been dropping in my inbox reviews of Harry Osters Legacy: A Genetic History of the Jewish People. The latest is in the The Tablet, A Case for Genetic Jewishness: For a Jewish genetics researcher, being told inprintthat Hitler would certainly have been very pleased by your work cant be pleasant. But thats what happened in 2010 toHarry Ostrer, a geneticist at the Albert Einstein College of Medicine, when he and his colleagues published astudyshowing that Jews in three different geographical areas had certain collections of genes that made them more biologically similar to one another than they were to non-Jews in the same regions Continue reading
Posted in Genetic medicine
Tagged college, genetic, genome, medicine, middle-east, post-, sharing, time, work
Comments Off
Gamida Cell Closes $10 Million E Financing Round Earmarked to Support the Global Commercialization of the Company’s …
JERUSALEM–(BUSINESS WIRE)– Gamida Cell announced today that it has closed an internal E financing round of $10 million. All major shareholders participated. The financing will be used to support the global commercialization of the companys lead cell therapy product, StemEx, in development as an alternative therapeutic treatment for patients with blood cancers, such as leukemia and lymphoma, who can be cured by bone marrow transplantation but do not have a matched bone marrow donor Continue reading
Posted in Cell Therapy
Tagged a-game-changer-, a-matched-bone, a-single-unit, analysis, continued, elbit-imaging, gamida, gamida-cells, market, reuven-krupik, shareholders
Comments Off
Stem cells boost brain tumor treatments for some patients, study finds
(CBS News) Patients with brain cancer may face devastating side effects from chemotherapy, but a new study offers a possible solution: stem cells. Yearly dental X-rays raise brain tumor risk, study finds Memorial Hermann hospital in Houston to live tweet brain tumor surgery The stem cells form a shield of sorts against the toxic side effects from chemo, according to the researchers behind the study Continue reading
Posted in Stem Cells
Tagged a-gene-often, a-remains-alive, a-small-trial, combination, giving-the-bone, jennifer-adair, patients-, research-, researchers, study, toxic, tumor, while-the-tumor
Comments Off
Increasing Investment in Stem Cell Technology and Promising Research Outcomes Drives the Stem Cell Research Market …
GIA announces the release of a comprehensive global report on the Stem Cell Research markets. The global Adult Stem Cell Research market is projected to reach US$3.2 billion by 2017. Continue reading
Posted in Stem Cell Therapy
Tagged 3-2-billion, adult, adult-stem, and-breakthrough, announces-the-release, factors-driving, global-report, governments, market, report-on-the, research-groups
Comments Off
Stem cell sparing radiotherapy for head and neck cancer may avoid salivary gland damage
Public release date: 9-May-2012 [ | E-mail | Share ] Contact: Emma Mason wordmason@mac.om European Society for Radiotherapy and Oncology (ESTRO) Barcelona, Spain: Researchers believe they may have found a way to avoid damaging salivary glands during radiotherapy treatment for head and neck cancer a discovery that could improve the quality of life of 500,000 patients a year worldwide with the disease. Presenting their findings to the 31st conference of the European Society for Radiotherapy and Oncology (ESTRO31) [1], the researchers said that they had discovered that the stem cells essential for regenerating the parotid gland (the largest pair of salivary glands) were located mainly in its major ducts, and that these could easily be avoided during radiotherapy or given a minimal radiation dose. Continue reading
Posted in Stem Cells
Tagged a-parotid-gland, centre, complication, european, gland, largest, location, medical-center, oncology, parts, radiotherapy, researchers, salivary, university
Comments Off
Alliance for Regenerative Medicine Holds Clinical Outlooks for Regenerative Medicine Meeting in Partnership With …
WASHINGTON, DC–(Marketwire -05/03/12)- The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced it will hold a conference titled, Clinical Outlooks for Regenerative Medicine 2012, in partnership with Harvard Stem Cell Institute on June 19, 2012. The meeting, being held at The Starr Center, Schepens Eye Research Institute, 185 Cambridge Street, Boston, MA, will assemble a group of ~200 leading regenerative medicine executives, clinicians and investigators from major research establishments and companies to discuss how these technologies are transforming the practice of medicine. Pioneering stem cell researcher George Q Continue reading
Posted in Integrative Medicine
Tagged boston, cambridge, development, genetics, medical, professor, research-, women
Comments Off
Blondeness In Solomon Islanders Due To Genetic Variations
Excess sun exposure, a diet rich in fish, and gene inheritance from ancient explorers and traders, are all possible theories why some dark-skinned indigenous Solomon Islanders are naturally blonde, according to new research published today in the journal Science. The study, led by Stanford University researchers, found that 5 to 10 percent of the indigenous Solomon population have a gene that is responsible for blondeness. Continue reading
Posted in Genetic medicine
Tagged a-diet-rich, africa, blonde, bristol, fascinating, school, solomon, solomon-islanders, stanford, study
Comments Off
The Best of Experimental Biology
From breast milk stem cells to bone repair, this years EB conference held a number of exciting advances that could one day be translated into therapies. Milk stem cells Australian scientists have found stem cells in breast milk that appear to behave much like embryonic stem cells. Continue reading
Posted in Stem Cells
Tagged a-certain-point, a-new-source, body-as-divers, brain, california, development, health, oxygen, raymond-quock, researchers, the-researchers, translated-into, tulanes-mimi, university
Comments Off
Hospital Angeles Regenerative Medicine Institute Tijuana Dr. Jesus Perez stem cells PART 1 – Video
23-04-2012 17:37 Warning! After spending $25000 on stem cells, the Regenerative Medicine Institute is IGNORING ME. They do not want to give me more stem cells unless I pay another $25000.00!!! THEY TOLD ME I ONLY NEEDED ONE TREATMENT!!! Continue reading
Posted in Regenerative Medicine
Tagged institute, medicine-institute, not-want, one-, pay-another, regenerative, stem-cells, warning
Comments Off
Scientists discover neural stem cells with tumour targeting ability
SINGAPORE: Scientists at Singapore's Institute of Bioengineering and Nanotechnology (IBN) have discovered that neural stem cells possess the innate ability to target tumour cells outside the central nervous system. Continue reading
Posted in Stem Cells
Tagged cells-outside, central, have-discovered, innate-ability, institute, nanotechnology-, nervous-system, outside-the-central, possess-the, scientists, scientists-at-singapore, singapore, target-tumour
Comments Off
SynGen Inc. Receives $5 million Equity Investment from Bay City Capital, LLC
SACRAMENTO, Calif., April 19, 2012 /PRNewswire/ — SynGen Inc. (“SynGen” or the “Company”), a Regenerative Medicine device company focused on the development of next generation stem cell harvesting systems, announced today that it has completed a $5 million Series A preferred stock financing with Bay City Capital, LLC (BCC). Under the terms of the transaction, BCC will appoint two representatives to SynGen’s board of directors. Continue reading
Posted in Regenerative Medicine
Tagged a-top-tier, accelerated, capital, during-the-due, focused-on-the, make-the-syngen, medical, opportunity, our-accelerated, syngen, transaction, under-the-terms, venture-capital, william-gerber
Comments Off
Lineagen Presents Data Showing Clinical Utilization of FirstStepDx®, a New Model of Genetic Service Delivery, at the …
Quotes delayed, except where indicated otherwise. Delay times are 15 mins for NASDAQ, NYSE and Amex Continue reading
Posted in Molecular Genetics
Tagged a-and-daily, accessing-the, actions-taken, are-delayed, commodity, daily-updates, fundamental, information, neither-yahoo, not-intended, partner-page-, purposes-only, the-information, yahoo
Comments Off
Stem cell therapy for the repair of myocardium in heart failure patients – Video
28-03-2012 10:17 Dr Joshua Hare is Professor of Medicine and Director of the Interdisciplinary Stem Cell Institute at the University of Miami. The interview was conducted on 25 March 2012 at the American College of Cardiology’s (ACC’s) 61st Annual Scientific Session & Expo in Chicago Continue reading
Posted in Cell Therapy
Tagged 2012-at-the, acc, annual, annual-scientific, chicago, institute, interdisciplinary, joshua-hare, professor, session
Comments Off
Natera Announces Presentations During the American College of Medical Genetics 2012 Annual Clinical Genetics Meeting
REDWOOD CITY, Calif.–(BUSINESS WIRE)– Natera, formerly known as Gene Security Network, today announced that data from studies of the companys bioinformatics Parental Support technology will be presented during the American College of Medical Genetics 2012 Annual Clinical Genetics Meeting at the Charlotte Convention Center in Charlotte, North Carolina. Matthew Rabinowitz, Ph.D., CEO of Natera, will deliver an oral presentation, abstract 59, titled First Trimester Non-invasive Detection of Fetal Aneuploidy 13, 18, 21, and X by Targeted Sequencing. Continue reading
Posted in Molecular Genetics
Tagged a-from-studies, a-single-cell, charlotte, director, dna, during-the-same, genetics, north-carolina, recurrent, security
Comments Off
Organogenesis CEO Geoff MacKay Elected Chairman of MassBio Board of Directors
CANTON, Mass., March 27, 2012 /PRNewswire/ –Today MassBio members elected Geoff MacKay, president & CEO of regenerative medicine leader Organogenesis Inc., as chairman of the board of directors at the 2012 MassBio Annual Meeting. (Photo: http://photos.prnewswire.com/prnh/20120327/NE76866) During this year’s meeting, MassBio members also elected three new board members: Caren Arnstein, senior vice president and Head of Communications for Genzyme, James Hoyes, President of EMD Serono, Inc., and David Lucchino, CEO of Semprus BioSciences Continue reading
Posted in Regenerative Medicine
Tagged a-two-year-term, annual-meeting, career, caren-arnstein, country--, development, future, industry, massachusetts, organogenesis-, pavilion-at-the, pharmaceutical
Comments Off
March 26, 2012
March 11, 2012 Third-year microbiology, immunology, and molecular genetics student Jeffrey Lin and second-year computer science and engineering student Kirby Cool are two seekers on the UCLA Quidditch team. After a winning match, they discuss their strategies and experiences in catching the golden snitch Continue reading
Posted in Molecular Genetics
Tagged a-winning-match, and-molecular, are-two, check-out-more, golden, golden-snitch-, march, out-more, seekers-on-the, third-year, winning-match
Comments Off